SMi Group is proud to present the 23rd annual industry leading summit on Pharmaceutical Pricing and Market Access, taking place on 11th & 12th October 2017 in Central London.
A surge in the price of drugs has recently been making international headline news adding growing pressure from leading government bodies and patient groups for pharmaceutical companies and manufactures to limit future price increases. Mounting criticism has created a shift in focus for payers to be more cost-effective in their approach to setting budgets and managing costs.
Drawing from over two decades worth of expertise, Pharmaceutical Pricing & Market Access 2017 will address these challenges head on by offering a detailed understanding of the payer landscape and preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical pricing market.
Join us this autumn for exclusive case study insight into how manufactures plan to limit future price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); and discuss what can be done by all stakeholders for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
Featured speakers include:
Reasons to Join:
11 Oct 2017
12 Oct 2017
Holiday Inn Kensington Forum
97 Cromwell Road
United Kingdom
English en